To study the efficacy ofAshwagandhadi Avaleha as an Adjuvant with Anti Tubercular Treatment.
Not Applicable
- Conditions
- Health Condition 1: J989- Respiratory disorder, unspecified
- Registration Number
- CTRI/2021/05/033863
- Lead Sponsor
- Principal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Freshly diagnosed cases of tuberculosis(Pulmonary Tuberculosis and Tubercular pleural
effusion)
2. Patients of either sex between the age of 15-70 years.
3. Patients willing and able to participate for 8 weeks duration
Exclusion Criteria
1. MDR and XDR cases of tuberculosis.
2. Patients having diabetes mellitus.
3. Patient with uncontrolled hypertension.
4. Suffering from any other chronic infections including HIV.
5. Patients Below the age of 15yrs and above the age of 70yrs.
6. Patients not willing for trial.
7. Individuals who have completed participation in any other clinical trial during the past three
months.
8. Any other condition which the Principal investigator thinks may jeopardize the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method